KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 252 filers reported holding KITE PHARMA INC in Q3 2017. The put-call ratio across all filers is 1.40 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $9,383,000 | +68.5% | 52,183 | -2.9% | 0.01% | +50.0% |
| Q2 2017 | $5,570,000 | +873.8% | 53,730 | +637.7% | 0.01% | +500.0% |
| Q1 2017 | $572,000 | +75.5% | 7,283 | +0.2% | 0.00% | – |
| Q4 2016 | $326,000 | -16.4% | 7,271 | +4.3% | 0.00% | -100.0% |
| Q3 2016 | $390,000 | +13.0% | 6,973 | +1.1% | 0.00% | – |
| Q2 2016 | $345,000 | +31.7% | 6,895 | +21.0% | 0.00% | – |
| Q1 2016 | $262,000 | -14.7% | 5,699 | +14.5% | 0.00% | – |
| Q4 2015 | $307,000 | +12.9% | 4,979 | +2.0% | 0.00% | – |
| Q3 2015 | $272,000 | +2.6% | 4,879 | +12.2% | 0.00% | – |
| Q2 2015 | $265,000 | – | 4,347 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |